- Home
- ILLR vs ORMP Comparison
ILLR vs ORMP Comparison
Compare ILLR & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILLR
- ORMP
- Stock Information
- Founded
- ILLR 2015
- ORMP 2002
- Country
- ILLR United States
- ORMP United States
- Employees
- ILLR N/A
- ORMP N/A
- Industry
- ILLR Investment Managers
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- ILLR Finance
- ORMP Health Care
- Exchange
- ILLR Nasdaq
- ORMP Nasdaq
- Market Cap
- ILLR 79.7M
- ORMP 90.2M
- IPO Year
- ILLR N/A
- ORMP N/A
- Fundamental
- Price
- ILLR $0.69
- ORMP $2.41
- Analyst Decision
- ILLR
- ORMP Hold
- Analyst Count
- ILLR 0
- ORMP 1
- Target Price
- ILLR N/A
- ORMP N/A
- AVG Volume (30 Days)
- ILLR 3.8M
- ORMP 99.1K
- Earning Date
- ILLR 11-13-2025
- ORMP 11-06-2025
- Dividend Yield
- ILLR N/A
- ORMP N/A
- EPS Growth
- ILLR N/A
- ORMP N/A
- EPS
- ILLR N/A
- ORMP N/A
- Revenue
- ILLR $45,244,000.00
- ORMP $2,000,000.00
- Revenue This Year
- ILLR N/A
- ORMP N/A
- Revenue Next Year
- ILLR N/A
- ORMP N/A
- P/E Ratio
- ILLR N/A
- ORMP N/A
- Revenue Growth
- ILLR N/A
- ORMP N/A
- 52 Week Low
- ILLR $0.40
- ORMP $1.82
- 52 Week High
- ILLR $6.52
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- ILLR 62.81
- ORMP 71.70
- Support Level
- ILLR $0.41
- ORMP $2.17
- Resistance Level
- ILLR $0.76
- ORMP $2.45
- Average True Range (ATR)
- ILLR 0.09
- ORMP 0.06
- MACD
- ILLR 0.03
- ORMP 0.03
- Stochastic Oscillator
- ILLR 70.08
- ORMP 88.24
About ILLR Triller Group Inc. Common Stock
Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.